Alopecia Treatment Market

Market Overview:

The global alopecia treatment market size reached US$ 3.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.1 Billion by 2028, exhibiting a growth rate (CAGR) of 4.75% during 2023-2028. The growing prevalence of genetic predispositions, rising unhealthy dietary patterns, and increasing exposure to pollutants and chemicals represent some of the key factors driving the market.

Alopecia refers to a medical condition that causes loss of hair on the scalp and other areas of the body. It includes androgenetic, areata, totalis, universalis, and telogen effluvium variants. It can affect people of all ages, genders, and ethnicities, and can be managed using various treatments, such as topical and oral medications, injections, and hair transplant procedures. These treatments block the attack of the immune system on the affected area and stimulate the regrowth of hair. At present, phototherapy or low light laser therapy (LLLT) is gaining traction across the globe as it is less invasive, safer, and more tolerable than traditional treatments.

Alopecia Treatment Market Trends:

The growing geriatric population, coupled with the increasing prevalence of alopecia due to various genetic predispositions, hormonal changes, and autoimmune disorders, represents one of the key factors positively influencing the market across the globe. In addition, sedentary lifestyles and the increasing exposure to pollutants, chemicals, and other environmental factors are contributing to alopecia. In line with this, the rising consumption of fast food that are low in vitamins, minerals, and protein are increasing the loss of hair on the scalp and other parts of the body. Moreover, a high intake of refined sugar and foods with higher values of saturated and trans fats are causing damage to hair fossils and contributing to inflammation and increasing the need for alopecia treatment worldwide. Apart from this, the increasing adoption of advanced technologies, such as ARTAS system, which uses advanced imaging technology and artificial intelligence (AI) algorithms for delivering permanent and natural results and considered faster, more precise, and more accurate than traditional hair restoration methods is fueling the market growth. In addition, the rising popularity of low-level laser therapy, which is non-invasive and involves laser beams to stimulate hair growth is contributing to the market growth. Besides this, the improving healthcare infrastructure and accessibility and increasing affordability of alopecia treatment are fueling the market. Furthermore, increasing investments in research and development (R&D) activities in the pharmaceutical industry and the growing awareness about alopecia treatment are anticipated to drive the market in the coming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global alopecia treatment market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on drug type, indication, gender, route of administration and distribution channel.

Drug Type Insights:

• Minoxidil
• Finasteride
• Others
   

The report has provided a detailed breakup and analysis of the alopecia treatment market based on the drug type. This includes minoxidil, finasteride, and others. According to the report, minoxidil represented the largest segment.

Indication Insights:

• Androgenic Alopecia
• Alopecia Areata
• Alopecia Totalis
• Others
   

A detailed breakup and analysis of the alopecia treatment market based on the indication has also been provided in the report. This includes androgenic alopecia, alopecia areata, alopecia totalis, and others. According to the report, androgenic alopecia accounted for the largest market share.

Gender Insights:

• Male
• Female
   

A detailed breakup and analysis of the alopecia treatment market based on the gender has also been provided in the report. This includes male and female. According to the report, female accounted for the largest market share.

Route of Administration Insights:

• Oral
• Topical
• Injectable
   

A detailed breakup and analysis of the alopecia treatment market based on the route of administration has also been provided in the report. This includes oral, topical, and injectable. According to the report, topical accounted for the largest market share.

Distribution Channel Insights:

• Hospitals
• Retail Pharmacies
• Online Pharmacies
   

A detailed breakup and analysis of the alopecia treatment market based on the distribution channel has also been provided in the report. This includes hospitals, retail pharmacies, and online pharmacies. According to the report, hospitals accounted for the largest market share.

Regional Insights:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa
   

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America (the United States and Canada) was the largest market for alopecia treatment. Some of the factors driving the North America alopecia treatment market included the aging population, technological advancements, high healthcare expenditure, etc.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global alopecia treatment market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Aclaris Therapeutics Inc., Cellmid Limited, Cipla Limited, Dr. Reddy’s Laboratories Ltd., GlaxoSmithKline plc, HCell Inc., Johnson & Johnson, Merck & Co. Inc., Pfizer Inc., Taisho Pharmaceutical Holdings Co. Ltd, Teva Pharmaceutical Industries Ltd. etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Report Coverage:

Key Benefits for Stakeholders:

• IMARC’s report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the alopecia treatment market from 2017-2028.
• The research study provides the latest information on the market drivers, challenges, and opportunities in the global alopecia treatment market.
• The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
• Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the alopecia treatment industry and its attractiveness.
• Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.